Steven Lister
EU Evidence Generation Strategy Lead, Rare Diseases UCB
Steve currently works as EU Evidence Generation Lead for rare disease at UCB. He is passionate about generating and interpreting high-quality evidence to communicate value & bring transformational medicines to patients.
He has 20+ years’ experience across a range of pharmaceutical companies in market research, health economics, and evidence generation, working to deliver solutions to clinical, health economic, HTA, value demonstration, and market access challenges, at all phases of the product lifecycle. His current focus is on sourcing and applying the most appropriate evidence to inform compelling value narratives for medicines to treat rare diseases.
Seminars
Thursday 26th February 2026
Using Real World Evidence to Build Credible, Transformational Value Narratives
4:15 pm
- Translate complex real-world data into clear, impactful narratives that resonate with payers, patients, and healthcare systems
- Discover practical approaches to bridge medical, access, and commercial teams for unified value communication while exploring how evidence-driven storytelling can strengthen stakeholder trust and long-term market success in an evolving valuebased landscape
- Conclude by looking ahead to a future where being more efficacious and safer is no longer enough and real-world impact defines success
